Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis [7]

American Journal of Gastroenterology

Volumn 102, Issue 3, 2007, Pages 689-691

  Chamberlin, William ^a   Ghobrial, George ^b   Chehtane, Mounir ^b   Naser, Saleh A ^b  

^a Texas Tech Medical Center   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; INFLIXIMAB; LEVOFLOXACIN; MERCAPTOPURINE; MESALAZINE; PREDNISONE; RIFABUTIN;

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; COLONOSCOPY; CROHN DISEASE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEVER; FLU LIKE SYNDROME; HUMAN; LETTER; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; COLONOSCOPY; CROHN DISEASE; DISEASE PROGRESSION; DNA, BACTERIAL; FOLLOW-UP STUDIES; HUMANS; MALE; MYCOBACTERIUM PARATUBERCULOSIS; PARATUBERCULOSIS; REMISSION INDUCTION; RISK FACTORS;

EID: 33847297550     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01040_7.x     Document Type: Letter

References (3)

1. Shafran I, Kugler L, El-Zaatari FA, et al. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis 2002;34:22-8.
2. Borody TJ, Leis S, Warren EF, et al. Treatment of severe Crohn's disease using antimycobacterial triple therapy - approaching a cure? Dig Liver Dis 2002;34:29-38.
3. Naser SA, Ghobrial G, Romero C, et al. 2004. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004;364:1039-44.